RxDoctor Payments Data

Ricardo Barzaga, MD

Infectious Disease · Atlantic City, NJNPI 1922044759

Payments from drug & device makers

$1,761in general payments, 2019–2025

Across 95 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Merck$307
  • Astellas Pharma US Inc$179
  • Viiv Healthcare Company$164
  • Melinta Therapeutics, LLC$25

What the payments were for

  • Food & beverage$1,56989%
  • Education$19211%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)68$1,085
Merck21$307
Astellas Pharma US Inc2$179
Viiv Healthcare Company2$164
Melinta Therapeutics, LLC2$25

How this compares

$1,761 in reported general payments places this provider in the 60th percentile of 334 infectious disease providers in New Jersey.

See all infectious disease providers in New Jersey

Medicare billing

Part B allowed, 2024
$44,843
Medicare patients
162
Services billed
514

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Atlantic City

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →